Can Wegovy (Semaglutide) Cause Tinnitus?

What the Evidence Actually Shows

If you searched "can semaglutide cause tinnitus" after noticing a ringing or buzzing in your ears while on Wegovy or Ozempic, you are not alone. Online patient forums have seen a growing number of people raising the same question. However, the clinical picture does not support a confirmed link.

Tinnitus is not listed as a known or common side effect in the FDA prescribing information for either Wegovy or Ozempic, nor did it emerge as a meaningful finding in the major clinical trials that led to semaglutide's approval. The FDA Adverse Event Reporting System (FAERS) does contain a small number of tinnitus reports associated with semaglutide, but the volume is low relative to the millions of people now using these medications. Importantly, reports in FAERS reflect correlation rather than causation. Anyone can submit a report, and the system is designed to flag signals for further investigation, not to confirm drug-induced effects.

As of 2025, no peer-reviewed studies have directly examined whether semaglutide affects cochlear function or auditory nerve signaling. The honest scientific answer is that the connection remains unproven.

Why Some Users Report Ear Ringing Anyway

Even without a confirmed pharmacological mechanism, there are plausible indirect reasons why some people on semaglutide may experience tinnitus or notice that existing tinnitus worsens.

Substantial weight loss can contribute to patulous Eustachian tube dysfunction in some people, which may cause ear symptoms such as fullness, autophony, or occasionally tinnitus. Evidence that this explains tinnitus during semaglutide treatment is limited, and other causes should be evaluated.

Nausea and vomiting, among the most common side effects of semaglutide, can transiently increase intracranial pressure. Some researchers have proposed a connection between elevated intracranial pressure and auditory changes, though this remains an area of ongoing study rather than settled science.

Dehydration is another factor worth considering. When GI side effects reduce fluid intake or cause significant fluid loss, blood volume can drop, potentially affecting perfusion to the highly vascular inner ear. The inner ear depends on a consistent supply of oxygenated blood to function normally, so any disruption to that supply may contribute to auditory symptoms.

GLP-1 Receptors and the Auditory System

One reason the tinnitus question persists scientifically is that GLP-1 receptors are not limited to the gut and pancreas. They are expressed across multiple organ systems, including nervous tissue. This distribution raises theoretical questions about whether GLP-1 agonists like semaglutide could influence auditory nerve activity.

However, a theoretical possibility is not the same as a demonstrated effect. No published research has traced a pathway from GLP-1 receptor activation to cochlear or auditory nerve changes in humans. Until that research exists, any proposed mechanism remains speculative. The presence of these receptors in nervous tissue is a reason to keep watching the science, not a reason to assume harm.

Sorting Out the Real Culprit

One of the biggest challenges in attributing tinnitus to semaglutide is the complexity of the population using it. Many people starting Wegovy or Ozempic are also managing other health conditions and taking other medications.

Several drug classes commonly used alongside GLP-1 therapy carry well-established ototoxic risk profiles. The table below summarizes how confirmed semaglutide side effects compare to reported but unconfirmed symptoms and to conditions that are sometimes mistakenly blamed on the medication.

Obesity itself is associated with higher rates of both tinnitus and hearing loss in epidemiological research. This means that some new cases of tinnitus appearing in people starting GLP-1 therapy may be coincidental, reflecting underlying risks that existed before the medication was introduced. Cardiovascular changes from significant weight loss, including blood pressure shifts, can also independently alter how tinnitus is perceived.

When the Symptom Needs Prompt Attention

Not all tinnitus carries the same clinical weight. Brief, mild bilateral tinnitus without other symptoms can often be discussed non-urgently with a clinician. Earlier assessment is appropriate if it persists, worsens, disrupts sleep or daily function, or is unilateral or pulsatile, or if neurologic symptoms, ear pain or drainage, dizziness, or hearing change occurs. However, certain presentations need faster evaluation.

Sudden onset tinnitus in one ear, particularly when accompanied by hearing loss, a sensation of fullness, or vertigo, should be assessed promptly regardless of what medications you are taking. Sudden sensorineural hearing loss is a medical urgency, and its management is time-sensitive.

If your tinnitus began shortly after starting semaglutide or after a dose increase, that timeline is medically relevant information. Bring it to your prescribing clinician rather than drawing conclusions on your own. Discuss stopping semaglutide with the prescribing clinician when feasible. Discontinuation can allow appetite, weight, and blood glucose to return toward pretreatment levels, particularly in people with diabetes, but semaglutide is not known to cause a withdrawal syndrome.

Talking to Your Doctor Effectively

Getting the most out of a clinical conversation about this symptom starts with preparation. Before your appointment, write down when the tinnitus started relative to your medication timeline, whether it affects one ear or both, and whether any other symptoms appeared alongside it, such as dizziness, muffled hearing, or a feeling of pressure.

Ask your prescribing doctor whether a temporary dose reduction might be a reasonable step before considering full discontinuation. In some cases, titrating more slowly can reduce GI side effects, which may in turn address some of the indirect factors described above.

Persistent tinnitus generally warrants hearing assessment, but do not wait four to six weeks when tinnitus is sudden, unilateral, pulsatile, associated with sudden or asymmetric hearing loss, vertigo, neurologic symptoms, or follows head injury. Sudden hearing loss requires same-day urgent evaluation. A full audiogram can help determine whether any measurable hearing change has occurred and guide further management. Doctronic offers free 24/7 AI consultations and connects you with board-certified clinicians through $39 video visits, making it easy to get a personalized assessment without waiting weeks for an appointment.

Frequently Asked Questions

Is tinnitus a listed side effect of Wegovy or Ozempic?

No. Tinnitus does not appear in the FDA prescribing information or clinical trial data for Wegovy or Ozempic. A small number of tinnitus reports exist in the FDA adverse event database, but the volume is low relative to the millions of people using these medications, and no causal link has been established.

Can rapid weight loss from semaglutide cause ear ringing?

It is possible. Rapid weight loss can alter Eustachian tube function and middle ear pressure, which may trigger or worsen tinnitus independent of the drug itself. Dehydration from GI side effects can also reduce inner ear blood flow. These indirect mechanisms may explain some reported cases without semaglutide being the direct cause.

Should I stop taking semaglutide if I develop tinnitus?

Do not self-discontinue semaglutide without speaking to your prescribing doctor first. Stopping abruptly carries its own risks. Report the symptom, provide a timeline of when it started relative to your dose, and ask whether a dose reduction might be an option while the cause is being evaluated.

Does Ozempic affect hearing or cause hearing loss?

There is no confirmed evidence that Ozempic causes hearing loss or significant auditory changes. GLP-1 receptors are present in nervous tissue, which raises theoretical questions, but no peer-reviewed research has directly examined semaglutide's effect on cochlear or auditory nerve function as of 2025.

How do I know if my tinnitus is from my medication or something else?

Determining the cause requires a clinical assessment. Key steps include comparing the timeline of symptom onset to when you started semaglutide or had a dose increase, reviewing other medications with ototoxic potential, and ruling out underlying conditions. An audiologist referral is appropriate if tinnitus persists for four to six weeks or longer.

The Bottom Line

Current evidence does not confirm that semaglutide causes tinnitus. The connection is unproven, and the FDA has not listed ear ringing as a known side effect of Wegovy or Ozempic. That said, indirect effects such as dehydration, GI-related pressure changes, and the physical demands of rapid weight loss may plausibly contribute to ear symptoms in some users. Co-existing medications and obesity-related hearing changes can also make it genuinely difficult to identify a single cause. If you notice new tinnitus while on a GLP-1 medication, report it to your doctor and track the symptom carefully. Doctronic has completed more than 22 million AI consultations and offers free 24/7 assessments to help you understand new symptoms quickly. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.